Meeting
2018 Genitourinary Cancers Symposium
Identification and characterization of circulating tumor cells in post prostatectomy patients with localized high risk prostate cancer.
Authors
Terence W. Friedlander
UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Terence W. Friedlander , Christopher J. Welty , Archana Anantharaman , Jeffrey Hough , Matthew Edwards , Alise Stromlund , Jeff Simko , Ryon Graf , Angel Rodriquez , Yipeng Wang , Peter Carroll , Matthew R. Cooperberg , Ryan Vance Dittamore , Pamela Paris
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 69)
DOI
10.1200/JCO.2018.36.6_suppl.69
Abstract #
69
Poster Bd #
D11
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Characterization of circulating tumor cells in patients with localized high risk prostate cancer, post-prostatectomy.
First Author: Terence W. Friedlander
Poster
2019 Genitourinary Cancers Symposium
A study of intense neoadjuvant testosterone lowering therapy with goserelin and enzalutamide (Enza) in high-risk prostate cancer (PC) with multiparametric MRI (mpMRI).
First Author: Fatima Karzai
Poster
2018 Genitourinary Cancers Symposium
Results of a phase II trial of neoadjuvant abiraterone + prednisone+ enzalutamide + leuprolide (APEL) versus enzalutamide + leuprolide (EL) for patients with high-risk localized prostate cancer (PC) undergoing radical prostatectomy (RP).
First Author: Rana R. McKay
Poster
2013 Genitourinary Cancers Symposium
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
First Author: Matthew R. Cooperberg